Sample | Dilution factora | Q-Con | Q-HT | Q-Sym | KFF | MP96 |
---|
1 | – | 4/4 | 4/4 | 4/4 | 4/4 | 4/4 |
2 | 1:2 | 4/4 | 4/4 | 4/4 | 4/4 | 4/4 |
3 | 1:4 | 4/4 | 4/4 | 4/4 | 4/4 | 2/2* |
4 | 1:10 | 4/4 | 4/4 | 4/4 | 4/4 | 4/4 |
5 | 1:20 | 4/4 | 4/4 | 4/4 | 4/4 | 4/4 |
6 | 1:40 | 4/4 | 4/4 | 3/4 | 4/4 | 4/4 |
7 | 1:100 | 3/4 | 3/4 | 1/4 | 2/4 | 3/4 |
8 | 1:200 | 0/4 | 0/4 | 1/4 | 1/4 | 1/2* |
9 | 1:400 | 0/4 | 1/4 | 1/4 | 0/4 | 1/4 |
10 | 1:1000 | 0/4 | 1/4 | 0/4 | 0/4 | 0/4 |
11 | 1:2000 | 0/4 | 0/4 | 1/4 | 0/4 | 0/4 |
- PCR positivity comparison was performed by using serial diluted cell culture supernatant of SARS-CoV-2. The number of positive rRT-PCR replicates is shown for each sample. The SARS-CoV-2 rRT-PCR assay targets two regions of the SARS-CoV-2 genome and was performed in duplicate, yielding a total of four PCR replicates per RNA extract
- Q-Con: QIAcube Connect, Q-HT: QIAcube HT, Q-Sym: QIAsymphony, KFF: King Fisher Flex, MP96: MagNa Pure 96
- aThe dilution factor relative to the most highly concentrated sample 1 is given in order to allow a relative comparison of performance around the limit of detection. In the pre-tests, sample 1 had a Ct value of 30 in both the E-Gene and orf1ab rRT-PCR assay
- *RNA analysis not performed in duplicate due to insufficient volume of RNA extract